101273
2-ブロモ-4′-クロロアセトフェノン
98%
別名:
ω-ブロモ-4-クロロアセトフェノン, 4-クロロフェナシルブロミド
ログインで組織・契約価格をご覧ください。
サイズを選択してください
この商品について
化学式:
ClC6H4COCH2Br
CAS番号:
分子量:
233.49
UNSPSC Code:
12352100
NACRES:
NA.22
PubChem Substance ID:
EC Number:
208-631-5
Beilstein/REAXYS Number:
607603
MDL number:
製品名
2-ブロモ-4′-クロロアセトフェノン, 98%
InChI key
FLAYZKKEOIAALB-UHFFFAOYSA-N
InChI
1S/C8H6BrClO/c9-5-8(11)6-1-3-7(10)4-2-6/h1-4H,5H2
SMILES string
Clc1ccc(cc1)C(=O)CBr
assay
98%
form
solid
mp
93-96 °C (lit.)
functional group
bromo
chloro
ketone
Quality Level
類似した製品をお探しですか？ 訪問 製品比較ガイド
signalword
Warning
hcodes
Hazard Classifications
Acute Tox. 4 Oral - Eye Irrit. 2 - Skin Irrit. 2 - STOT SE 3
target_organs
Respiratory system
保管分類
11 - Combustible Solids
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
ppe
Eyeshields, Faceshields, Gloves, type P3 (EN 143) respirator cartridges
Daniel I Perez et al.
Journal of medicinal chemistry, 54(12), 4042-4056 (2011-04-20)
Development of kinase-targeted therapies for central nervous system (CNS) diseases is a great challenge. Glycogen synthase kinase 3 (GSK-3) offers a great potential for severe CNS unmet diseases, being one of the inhibitors on clinical trials for different tauopathies. Following
Shigeo Hayashi et al.
Journal of enzyme inhibition and medicinal chemistry, 29(6), 846-867 (2014-02-13)
Because of the pivotal role of cyclooxygenase (COX) in the inflammatory processes, non-steroidal anti-inflammatory drugs (NSAIDs) that suppress COX activities have been used clinically for the treatment of inflammatory diseases/syndromes; however, traditional NSAIDs exhibit serious side-effects such as gastrointestinal damage
ライフサイエンス、有機合成、材料科学、クロマトグラフィー、分析など、あらゆる分野の研究に経験のあるメンバーがおります。.
製品に関するお問い合わせはこちら（テクニカルサービス）